Table 2.
Efficacy of vaccines targeted towards infectious disease can be enhanced by inorganic NMs.
Immune Setting | Inorganic NM | Effect | Ref. |
---|---|---|---|
Infectious disease | AuNPs | Antibody production against foot-and-mouth disease peptide was dependent on NP size | 95 |
Delivering antigen and adjuvant reduced viral load in liver infection model | 80 | ||
Antigen and adjuvant codelivery led to complete protection from lethal influenza challenge |
96 97 |
||
Adjuvant delivery resulted in 100% survival in a select agent lethal challenge model |
81 99 100 |
||
AuNMs | Surface area was correlated to cytokine and antibody production against West Nile virus envelope protein | 82 | |
Gold nanostars served as a strong adjuvant in foot-and-mouth disease vaccination | 101 | ||
Delivery of a DNA vaccine resulted in 100% protection from newcastle disease virus challenge | 83 | ||
Antigen delivery resulted in strong, long-lasting antibody and cell-mediated responses against bovine viral diarrhea virus |
84 102 103 |
||
QDs | Inhibited replication of herpes simplex virus-1 | 51 |